Home » News & Updates » International Conference on Cardiac Biomarkers (CARDBIOCON 2024) Unveils Latest Breakthroughs in Cardiovascular Medicine

International Conference on Cardiac Biomarkers (CARDBIOCON 2024) Unveils Latest Breakthroughs in Cardiovascular Medicine

The Centre for Clinical Pharmacology at SRM Medical College Hospital and Research Centre and a grant from Zurich University of Applied Sciences, Switzerland, the International Conference on Cardiac Biomarkers (CARDBIOCON 2024) illuminated the forefront of cardiovascular medicine

The International Conference focuses on – Advancing the understanding of biomarkers in cardiac diseases including, Coronary Artery Diseases (CAD), Acute Myocardial Infarction, and Congestive Heart Failure.

The conference convened esteemed dignitaries and experts from across the globe including,
➢ Prof. (Dr.) Nitin M Nagarkar, Dean (Medical) at SRMMCH&RC
➢ Dr. R. Venkatraman, Medical Superintendent at SRMMCH&RC
➢ Prof. Dr. Melvin George, Head of the Centre for Clinical Pharmacology at SRMMCH&RC
➢ Dr. Chakradhara Rao Uppugunduri from the University of Geneva, Switzerland
➢ Dr. Georg B Ehret, Professor at the Division of Cardiology, Geneva University Hospitals

The scientific sessions were enriched by the expertise of renowned professionals like
~ Dr. Georg Ehret, Professor, Division of Cardiology, Geneva University Hospitals, La Geneva
~ Dr. Toishi Sharma, Interventional Cardiology Fellow Physician, University of Vermont, USA
~ Dr. Nagendra Boopathy, Professor, Interventional Cardiology, SRIHER, Chennai
~ Dr. Sagartirtha Sarkar, Professor, Genetics and Molecular Cardiology Laboratory, University of Calcutta, Kolkata
~ Dr. Sreehari Jathanakodi, Business Development Manager, O link Proteomics, Uppsala, Sweden
~ Dr. Sarantis Chlamydas, Scientific Affairs, Director of MultiOmics, Uppsala, Sweden
~ Dr. Subiksha. A, Medical Advisor, Boehringer Ingelheim, Chennai
~ Dr. Anichavezhi Devendran, Instructor, Icahn School of Medicine, Mount Sinai, New York, USA

In addition to scholarly discourse, the conference witnessed spirited participation in competitive events including oral/poster presentations and research quizzes, further fostering collaboration and knowledge exchange among delegates.

CARDBIOCON 2024 emerges as a beacon of innovation and collaboration, propelling cardiovascular medicine towards new horizons in diagnosis, treatment, and patient care.